Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Journal of the Neurological Sciences|February 7, 2018
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patientsEdgardo Cristiano, Ricardo Alonso, Amelia Alvez Pinheiro, et al.
Neurological Research|October 2, 2022
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEMZanga Gisela, Portinari Carla, Barber Josefina, et al.
Journal of the Neurological Sciences|May 26, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registryMaria A Piedrabuena, Jorge Correale, Marcela Fiol, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.
The Lancet. Neurology|September 20, 2025
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
Multiple Sclerosis and Related Disorders|May 26, 2019
The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directionsJuan Ignacio Rojas, Adriana Carrá, Jorge Correale, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?Geraldine G Luetic, María Laura Menichini, Carlos Vrech, et al.
JAMA Neurology|July 13, 2026
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAndreu Vilaseca, Philippe A Bilodeau, Georgios Gakis, et al.
Multiple Sclerosis and Related Disorders|June 25, 2021
Status of the neuromyelitis optica spectrum disorder in Latin AmericaVictor M Rivera, Fernando Hamuy, Veronica Rivas, et al.
Pageof 23